semaglutide cognitive effects Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss How might GLP-1 drugs like

So for people with Type 2 diabetes or obesity-linked metabolic disease, this could be life-changing

Nonetheless, semaglutide treatment drastically alleviated the effects of reserpine-induced hyperalgesia, exhibiting an impressive rise in thermal pain behavior latency, tail withdrawal latency, and limb withdrawal threshold

Or being afraid of intervention

For people who cannot tolerate GI side effects or who have medical conditions that make GLP-1 agonists risky, this safety differential is not a minor footnote

Of note, rates of discontinuation due to of AEs were lower with semaglutide than with liraglutide (3.2% vs

Both semaglutide and tirzepatide reduce insulin resistance and improve insulin sensitivity, critical for patients managing excess weight, blood sugar, and metabolic-associated liver disease